Concord Medical Services (NYSE:CCM) Share Price Crosses Above 200 Day Moving Average – Time to Sell?

Shares of Concord Medical Services Holdings Limited (NYSE:CCM) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $4.22 and traded as high as $4.88. Concord Medical Services shares last traded at $4.6460, with a volume of 41,926 shares traded.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a research report on Tuesday, May 26th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Concord Medical Services currently has an average rating of “Sell”.

Concord Medical Services Stock Performance

The company has a debt-to-equity ratio of 1.33, a quick ratio of 0.46 and a current ratio of 0.48. The firm has a 50-day moving average price of $4.63 and a 200-day moving average price of $4.22.

Concord Medical Services (NYSE:CCM) last announced its earnings results on Wednesday, April 29th. The company reported ($1.08) earnings per share for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.